LAMA2 and hepatocellular carcinoma: Our results show that Lama2 have a negative effect on the proliferation of hippocampal NSCs, keeping consistency with its roles in the malignant progression of lung adenocarcinoma [34], pituitary adenoma [35], hepatocellular carcinoma [36], and colorectal cancer [37].